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Expression proﬁlingThe concept of cancer stem cells (CSCs) claims that colorectal carcinomas (CRCs), like normal colorectal epithe-
lium, are organized hierarchically and contain a subpopulation of qualitatively distinct cancer cells. The expres-
sion of distinctive surface markers or of certain enzymes is a prerequisite for the isolation and characterization
of the CSC population. With respect to CRCs, putative CSCs can be identiﬁed by leucine-rich-repeat-containing
G-protein-coupled receptor 5 (Lgr5, also known as G-protein-coupled receptor 49, Gpr49). However, the precise
function of the intestinal stem cellmarker Lgr5 inCRCs remains largely unknown.We silenced LGR5 expression in
SW480 CRC cells via lentiviral shRNA constructs. This led to the depletion of a morphologically distinct subpop-
ulation of SW480 CRC cells.Microarray gene expression proﬁling revealed a down-regulation of NOTCH signaling
upon LGR5 silencing that could be conﬁrmed by immunohistochemistry. Furthermore, we induced
inﬂammation-driven colon tumors in Lgr5-EGFP-IRES-Cre-ERT2mice via administration of azoxymethane and
dextrane sodium sulfate. The induced tumors were ﬂow-sorted into fractions of epithelial cells that expressed
high or low levels of Lgr5 and were characterized using gene expression proﬁling. Lgr5 high tumor cells showed
higher levels of several stem cell-associated genes and higher Wnt signaling than Lgr5 low tumor cells and Lgr5
high normal stem cells. Here we provide a thorough description of our two gene expression datasets including
quality control checks uploaded to Gene Expression Omnibus database (data accession number: GSE46200).
The analysis and interpretation of our gene expression data and related results have been published recently
by Hirsch and colleagues in Carcinogenesis in 2014.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).cer cell line/
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Experimental design
Weaimed to characterize the transcriptomeof CRC cells as a function
of LGR5 expression. Therefore, we silenced the expression of LGR5 in
SW480 CRC cells via shRNA. SW480 is composed of twomorphologically
distinct subpopulations, i.e., spheres and adherent cells. LGR5 silencing
resulted in a loss of spheres. To analyze the underlyingmolecular mech-
anisms, we then analyzed changes in gene expression by microarrays
comparing shLGR5 with control cells and adherent cells with spheres.
Furthermore, we performed gene expression analyses of ex vivo isolated
colon tumors ﬂow-sorted into an Lgr5 high and an Lgr5 low fraction.We
exposed Lgr5-EGFP-IRES-Cre-ERT2mice, which harbor one EGFP-tagged
Lgr5 allele, to azoxymethane/dextrane sodium sulfate (AOM/DSS) to in-
duce inﬂammation-driven colon tumors. Single cell suspensions werethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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colon tumors and ﬂow-sorted into Lgr5 high and low cells based on
GFP expression (Fig. 1). The ﬂow-sorted cell fractionswere then charac-
terized using gene expression proﬁling.
Lentiviral transduction of SW480 CRC cells
Lentiviral shRNA transduction of SW480 cells was done using high-
titer lentivirus (Clone ID: V3LHS_635055, Open Biosystems, Thermo
Fisher Scientiﬁc, Lafayette, CO) according to themanufacturer's instruc-
tions. Knockdown efﬁciency was conﬁrmed by real-time qRT-PCR.
Microarray gene expression proﬁling of SW480 CRC cells
Total RNA was isolated from SW480 shLGR5 and control cells, and
from SW480 spheres and adherent cells using the RNeasy Mini Kit
(Qiagen, Hilden, Germany) including DNase I treatment (RNase-Free
DNase Set, Qiagen). RNA concentration and purity were measured by
spectrophotometry (NanoDrop 1000 Spectrophotometer, NanoDrop
products, Wilmington, DE). RNA integrity was assessed by 2100
Bioanalyzer (RNA 6000 Nano LabChip Kit, Agilent Technologies, Inc.,
Santa Clara, CA). For all samples a RNA integrity number greater than
eight could be achieved. Appropriate LGR5 status was conﬁrmed by
real-timeqRT-PCR. Total RNAwas labeled using theQuickAmp Labeling
Kit, one-color (Agilent) and subsequently hybridized on Human GE
4x44K v2 Microarrays (Agilent) according to the manufacturer's proto-
col version 6.5. Brieﬂy, 700 ng of total RNA was reverse transcribed and
Cy3-labeled cRNAwas prepared using a T7RNApolymerase. Concentra-
tion, purity and dye incorporation of Cy3-labeled cRNA were measured
by NanoDrop. Labeled cRNA yield and speciﬁc activity both were above
the cut-off values deﬁned by Agilent for all labeled samples. Slides were
scanned with microarray scanner G2565BA (Agilent). Images were
analyzed anddatawere quality controlled using Feature Extraction soft-
ware version 10.7.1.1 (Agilent). Quality control (QC)metricswerewith-
in the “good” range for all hybridized samples based on QC criteria
deﬁned by Agilent. Three independent experiments were performed
for each cell fraction using separately cultured cells for each experiment.
Mouse model of carcinogen-induced inﬂammation-driven
colon tumorigenesis
Heterozygous Lgr5-EGFP-IRES-CreERT2 mice [strain B6.129P2-
Lgr5tm1(cre/ERT2)Cle/J, henceforth referred to as ‘Lgr5-EGFP mice’] wereFig. 1.Workﬂow of ﬂow sorting AOM/DSS-induced mouseordered from Jackson Laboratory (Bar Harbor, ME) [1]. All mice were
bred and housed in a pathogen-free environment and used in experi-
ments in accordance with institutional guidelines at the Center for Can-
cer Research, National Cancer Institute, National Institutes of Health. All
experimental procedures conducted in this studywere approved by the
Animal Care and Use Committee of the National Institutes of Health. To
induce colon tumors, Lgr5-EGFP-IRES-CreERT2 mice aged two to four
months were injected with AOM (12.5 μg/g body weight; A5486,
Sigma, St. Louis, MO) twice and subjected to three cycles of DSS (2.5%
w/v;MW= 36,000–50,000,MPBiomedicals, Solon, OH) in the drinking
water [2,3]. Tumor growth was monitored by colonoscopies. About
100 days after the ﬁrst AOM injection, mice were sacriﬁced.Preparation of single cell suspensions and ﬂow sorting of normal mouse
colons and mouse colon tumors
Freshly isolated mouse colon tissue (normal or tumor) was washed
in ice-cold PBS. Cleaned tissue wasminced into 15ml of collagenase so-
lution [RPMI with collagenase D (5 mg/ml; Roche Applied Science,
Indianapolis, IN), FBS (5% v/v) and DNase I (1 μg/ml; Sigma, St. Louis,
MO)] using two scalpels and incubated on a platform shaker at 37 °C
for one hour. During the incubation period, tissue was gently pipetted
up and down at least 10 times every 15 min to release as many cells
as possible from the minced tissue pieces. Next, tissue and media mix-
ture was passed over a 70-μm followed by a 40-μm cell strainer (both
BD Falcon™, BD Biosciences, San Jose, CA). To minimize cell death and
alteration in gene expression, we immediately continued with staining
for ﬂow cytometry. After the removal of collagenase solution, cells
were incubated in Fc blocking solution [PBS with FBS (2% v/v), CD16/
CD32 (2% v/v; BD Pharmingen™, BD Biosciences) and donkey serum
(5% v/v; Sigma)] on ice for 20 min. Fc blocking solution was then re-
moved and cells were stained with Anti-EpCAM rat monoclonal anti-
body conjugated to allophycocyanin [1:400 dilution in PBS with FBS
(2% v/v) to a total volume of 600 μl for normal mouse colons and 400
to 800 μl for mouse colon tumors depending on tumor size; clone
G8.8, eBioscience, San Diego, CA] on ice for 30 min. Cells were then
washed and resuspended in 0.5 ml to 1.5 ml (depending on pellet
size) of PBS with FBS (2% v/v). To exclude dead cells, 7-AAD (BD
Pharmingen™, BD Biosciences) was added shortly before starting the
sorting process. Lgr5-EGFP high/EpCAM high/7-AAD negative cells and
Lgr5-EGFP low/EpCAM high/7-AAD negative cells were ﬂow-sorted
using a FACSAria II system (BD Biosciences). After sorting, cells were
collected in RPMI with HEPES (50 mM) and FBS (50% v/v), and wecolon tumors for Lgr5. Colon tumor region is circled.
Fig. 2. Ingenuity pathway analysis reveals an up-regulation of the NOTCH pathway in LGR5 high SW480 spheres compared to LGR5 low SW480 adherent cells. Red, genes up-regulated in
LGR5 high spheres; green, genes down-regulated in LGR5 high spheres. The intensity of the color is correlated with fold change. All color labeled genes show a Nthreefold differential ex-
pression and pass a threshold of FDR b0.05.
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using both FACSDiva software version 6.0 (BD Biosciences) and FlowJo
software version 9.5.2 (Tree Star Inc., Ashland, OR).RNA ampliﬁcation and microarray gene expression proﬁling of ﬂow-sorted
normal mouse colons and mouse colon tumors
RNAwas isolated from ﬂow-sorted normalmouse colons andmouse
colon tumors without delay using the DNA/RNA AllPrep Micro Kit
(Qiagen) according to the manufacturer's instructions. We conﬁrmed
by real-time qRT-PCR that GFP high ﬂow-sorted cells had signiﬁcantly
higher Lgr5 expression levels than GFP low ﬂow-sorted cells. Isolated
RNA was ampliﬁed together with spike-ins (1 μl of a 1:50,000 dilution
per reaction, One-Color RNA Spike-In Kit, Agilent) using the Ovation
PicoWTA System (NuGEN Technologies, Inc., San Carlos, CA). Ampliﬁed
cDNA was puriﬁed using the QIAquick PCR Puriﬁcation Kit (Qiagen)
before concentration and purity were measured by NanoDrop. Two μg
of ampliﬁed cDNA were labeled using the BioPrime® Total Genomic
Labeling Module (Invitrogen, Life Technologies, Carlsbad, CA). Concen-
tration, purity and dye incorporation of Alexa Fluor® 3 labeled cDNA
were measured by NanoDrop. Labeled cDNA yield and speciﬁc activity
were both within the expectations for all labeled samples. Subsequent-
ly, 4 μg of Alexa Fluor® 3 labeled targetwas hybridized onWholeMouse
Genome Microarrays 4x44K (Agilent) according to NuGEN's Agilent
Solution Application Note #1. Scanning, image analysis and data quality
control were done as for SW480 CRC cells. QC metrics were within
the expectations for all hybridized samples. Fifteen independentexperiments were performed using seven individual mice for normal
colons and eight for tumors.
Microarray gene expression analysis
Log2 intensities were normalized to the 75% percentile according to
themanufacturer's protocol (Agilent). Only probeswith intensities higher
than 50 were used for the analysis. Unsupervised hierarchical clustering
with Euclidean distance and Ward method was performed with Geno-
mics Suite™ software (Partek Incorporated, St. Louis, MO). The corre-
sponding functional annotation of differentially expressed genes and
their afﬁliation with speciﬁc genetic pathways was interrogated using
Ingenuity Pathway Analysis software (Ingenuity Systems, Redwood
City, CA). Microarray gene expression data have been deposited in Gene
Expression Omnibus database (data accession number: GSE46200).
Discussion
Here, we provide information about two gene expression datasets of
CRC stem-like cells deﬁned by LGR5 expression. These two datasets
have been analyzed and interpreted in a study published recently [4].
In the ﬁrst dataset LGR5 was silenced in human SW480 CRC cells
actively via shRNA and gene expression differences of shLGR5 cells
were analyzed compared with the original cell population. Given that
LGR5 silencing resulted in a loss of spheres, we additionally compared
adherent cells with spheres. Spheres expressed higher levels of several
stem cell-associated genes including LGR5, SOX2, ALDH1A1 and SMOC2,
Fig. 3. Principal component analysis shows a well separation between normal colons and
AOM/DSS-induced tumors. Also, there is a well separation between Lgr5 high and low
tumor cells. The separation between Lgr5 high and low normal colon cells is less
pronounced. Paired Lgr5 high and low samples are linked by lines.
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ly, the NOTCH signaling pathway was down-regulated in shLGR5 cells,
which could be conﬁrmed immunohistochemically using an antibodyagainst cleaved NOTCH1. The second dataset catalogs gene expression
of Lgr5 high tumor stem-like cells frommurine colon tumors on a single
mouse level. We induced colon tumors in Lgr5-EGFP-IRES-Cre-ERT2
mice via administration of AOM and DSS. Resulting tumors were ﬂow-
sorted into Lgr5 high and Lgr5 low fractions. Our approach without
pooling of samples required an RNA ampliﬁcation step prior to gene
expression proﬁling. Reassuringly, stem cell-speciﬁc genes including
Lgr5 and Smoc2were up-regulated in Lgr5 high cells. Both principal com-
ponent analysis and hierarchical clustering showed a clear separation of
Lgr5 high and low tumor cells, which was less obvious in normal cells
(Fig. 3). Furthermore, the Wnt signaling pathway was up-regulated
within the Lgr5 high tumor cell fraction.Acknowledgments
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